Showing results (21-30 of 416) with videos related to

Sort By:
Pageof 42
Transplantation|November 5, 1997
Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allograftsM Nishihara, M Gotoh, H Ohzato, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2003
An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreasJ Okami, S Nakamori, H Yamamoto, et al.
Transplantation|October 26, 1999
Participation of the liver in generation of a vigorous anti-donor response after inoculation of donor spleen cellsL He, M Gotoh, K Dono, et al.
Digestive Diseases and Sciences|March 29, 2001
Evaluation of regional liver damage by magnetic resonance imaging with superparamagnetic iron oxide in rat liverT Murakami, T Kim, M Takamura, et al.
British Journal of Cancer|November 26, 1999
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinomaY Ito, N Matsuura, M Sakon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2001
[A case of postoperative multiple hepatic metastasis from esophageal cancer successfully treated by surgical resection and hepatic arterial infusion chemotherapy]H Nagano, M Sakon, T Yasuda, et al.
Hepatology (Baltimore, Md.)|October 5, 2001
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasmN Hayashi, H Yamamoto, N Hiraoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2001
[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization]T Yamamoto, H Nagano, M Sakon, et al.
International Journal of Oncology|February 17, 2001
Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCRA Miyamoto, H Nagano, M Sakon, et al.
Digestive Diseases and Sciences|August 29, 2000
Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failureH Eguchi, K Umeshita, M Sakon, et al.
Pageof 42